Topical nepafenac as a treatment for CME
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Patients with high genetic risk of AMD should avoid instant coffee, investigators say
Investigators obtained data from genome‐wide association studies to examine the effects of instant coffee consumption
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
European Commission grants label extension for Eylea 8 mg with extended 6-month treatment interval
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Custom matching IOLs is key to managing patient satisfaction
Johann Krüger, MD, shares insights from 26 years of experience
Three-year outcomes of aflibercept 8mg in neovascular age related macular degeneration and diabetic macular edema